← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest quality evidence only (79)Meta-analysis (20)Treatment guideline (4)Phase 3 study (27)Randomized trial (14)Systematic review (14)Clinical trial (677)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Opportunistic diseases in patients with HIV infection in the intensive care unit. (2018/11/21) ♡
• The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C. (2018/11/21) ♡
• Proper patient education improves hepatitis C patients' disease-related knowledge and antiviral treatment acceptance in rural China. (2018/11/20) ♡
• A case of sofosbuvir-based treatment for chronic hepatitis C in end-stage renal disease. (2018/11/20) ♡
• Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country. (2018/11/08) ♡
• Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy. (2018/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current Management of Hepatic Encephalopathy. (2018/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis B and C. (2018/11/01) ♡
• Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease. (2018/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. DRESS syndrome induced by telaprevir: a potentially fatal adverse event in chronic hepatitis C therapy. (2018/11/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Association of the Body Mass Index with the Presence of Gastroesophageal Varices in Compensated Cirrhotic Patients with Hepatitis C Viral Infection. (2018/11/01) ♡
• Antiviral drugs have made hepatitis C eminently treatable. (2018/11/01) ♡
• Comparative efficacy of sofosbuvir-ribavirin versus sofosbuvir-daclatasvir for treatment of chronic hepatitis C in an area with limited NS5A inhibitor availability. (2018/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Improvement in Waldenström's Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals. (2018/10/16) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis. (2018/10/16) ♡
• Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease. (2018/10/16) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals. (2018/10/03) ♡
• Corrigendum to "Multidisciplinary approach to optimize management of patients with chronic hepatitis C and alcoholic liver disease" [J Formos Med Assoc (2016) 1097-1098]. (2018/10/01) ♡
• Assessing Racial Disparities in HCV Infection and Care Outcomes in a Southern Urban Population. (2018/10/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systematic review of acute pancreatitis associated with interferon-α or pegylated interferon-α: Possible or definitive causation? (2018/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Aggressive hepatocellular carcinoma occurring during direct antiviral therapy. (2018/10/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication. (2018/10/01) ♡
• Skeletal muscle fat deposition is associated with hepatocellular carcinoma development in patients with chronic liver disease. (2018/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful treatment of chronic hepatitis C infection with crushed elbasvir/grazoprevir administered via a percutaneous endoscopic gastrostomy tube. (2018/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Chronic hepatitis C virus infection in patients with nonoropharyngeal head and neck cancers. (2018/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection. (2018/10/01) ♡
• Assessing the cost-effectiveness of hepatitis C screening strategies in France. (2018/10/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. CHRONIC HEPATITIS C IS STILL A PROBLEM FOR THE PUBLIC HEALTH CARE SYSTEM IN BRAZIL. (2018/10/01) ♡
• HEPATITIS C IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM: BURDEN OF DISEASE. (2018/10/01) ♡
• WAITING DAAS LIST MORTALITY IMPACT IN HCV CIRRHOTIC PATIENTS. (2018/10/01) ♡
• PROFILE OF PATIENTS WITH CHRONIC HEPATITIS C IN A PUBLIC HEALTH PROGRAM IN SOUTHERN BRAZIL. (2018/10/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Characterization of In vitro inhibitory effects of consensus short interference RNAs against non-structural 5B gene of hepatitis C virus 1a genotype. (2018/10/01) ♡
• A study on the circulating genotypes of hepatitis C virus in a tertiary care hospital in Central Kerala. (2018/10/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A SEVERE CASE OF HYPERGLYCEMIA IN A KIDNEY TRANSPLANT RECIPIENT UNDERGOING INTERFERON-FREE THERAPY FOR CHRONIC HEPATITIS C. (2018/10/01) ♡
• Soluble Markers of Immune Activation Differentially Normalize and Selectively Associate with Improvement in AST, ALT, Albumin, and Transient Elastography During IFN-Free HCV Therapy. (2018/09/07) ♡
• Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients. (2018/09/01) ♡
• Impact of Direct Acting Antiviral Drugs in Treatment Naïve HCV Cirrhosis on Fibrosis and Severity of Liver Disease: A Real Life Experience from a Tertiary Care Center of North India. (2018/09/01) ♡
• Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV). (2018/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for metaflammation and NASH. (2018/09/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis. (2018/09/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Differential diagnosis of ascites in internal medicine: clinical case. (2018/08/27) ♡
• Effect of MBOAT7 variant on hepatitis B and C infections in Moroccan patients. (2018/08/16) ♡
• Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer. (2018/08/02) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. (2018/08/01) ♡
• Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India. (2018/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity. (2018/07/27) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Irreversible impact of chronic hepatitis C virus infection on human natural killer cell diversity. (2018/07/25) ♡
• Economic Evaluation of the Hepatitis C Virus Treatment Extension to Early-Stage Fibrosis Patients: Evidence from the PITER Real-World Cohort. (2018/07/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new? (2018/07/01) ♡
• Does Histopathology of Implanted Kidney According to Banff 07 Help Predict Long-term Transplantation Outcome? (2018/07/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.